Report cover image

Global Sertraline Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 198 Pages
SKU # APRC20553504

Description

Summary

According to APO Research, The global Sertraline market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Sertraline is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Sertraline is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Sertraline is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Sertraline is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Sertraline include Teva, Sun Pharmaceutical, Mylan, Pfizer, Torrent Pharmaceuticals, Oxford Pharma, Neurocon Inc, Lupin Pharmaceuticals and Lifecare Neuro, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Sertraline, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Sertraline, also provides the sales of main regions and countries. Of the upcoming market potential for Sertraline, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Sertraline sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Sertraline market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Sertraline sales, projected growth trends, production technology, application and end-user industry.

Sertraline Segment by Company

Teva
Sun Pharmaceutical
Mylan
Pfizer
Torrent Pharmaceuticals
Oxford Pharma
Neurocon Inc
Lupin Pharmaceuticals
Lifecare Neuro
Healing Pharma India Pvt Ltd
Camber Pharmaceuticals
Aurobindo Pharma
APOTEX
Sertraline Segment by Type

Tablet
Oral Concentrate
Sertraline Segment by Application

Adult
Children
Sertraline Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sertraline market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sertraline and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sertraline.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Sertraline market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sertraline manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Sertraline in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Sertraline in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

198 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Sertraline Market Size, 2020 VS 2024 VS 2031
1.3 Global Sertraline Market Size Estimates and Forecasts (2020-2031)
1.4 Global Sertraline Sales Estimates and Forecasts (2020-2031)
1.5 Global Sertraline Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Sertraline Market Dynamics
2.1 Sertraline Industry Trends
2.2 Sertraline Industry Drivers
2.3 Sertraline Industry Opportunities and Challenges
2.4 Sertraline Industry Restraints
3 Sertraline Market by Manufacturers
3.1 Global Sertraline Revenue by Manufacturers (2020-2025)
3.2 Global Sertraline Sales by Manufacturers (2020-2025)
3.3 Global Sertraline Average Sales Price by Manufacturers (2020-2025)
3.4 Global Sertraline Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Sertraline Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Sertraline Manufacturers, Product Type & Application
3.7 Global Sertraline Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Sertraline Market CR5 and HHI
3.8.2 Global Top 5 and 10 Sertraline Players Market Share by Revenue in 2024
3.8.3 2024 Sertraline Tier 1, Tier 2, and Tier 3
4 Sertraline Market by Type
4.1 Sertraline Type Introduction
4.1.1 Tablet
4.1.2 Oral Concentrate
4.2 Global Sertraline Sales by Type
4.2.1 Global Sertraline Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Sertraline Sales by Type (2020-2031)
4.2.3 Global Sertraline Sales Market Share by Type (2020-2031)
4.3 Global Sertraline Revenue by Type
4.3.1 Global Sertraline Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Sertraline Revenue by Type (2020-2031)
4.3.3 Global Sertraline Revenue Market Share by Type (2020-2031)
5 Sertraline Market by Application
5.1 Sertraline Application Introduction
5.1.1 Adult
5.1.2 Children
5.2 Global Sertraline Sales by Application
5.2.1 Global Sertraline Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Sertraline Sales by Application (2020-2031)
5.2.3 Global Sertraline Sales Market Share by Application (2020-2031)
5.3 Global Sertraline Revenue by Application
5.3.1 Global Sertraline Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Sertraline Revenue by Application (2020-2031)
5.3.3 Global Sertraline Revenue Market Share by Application (2020-2031)
6 Global Sertraline Sales by Region
6.1 Global Sertraline Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Sertraline Sales by Region (2020-2031)
6.2.1 Global Sertraline Sales by Region (2020-2025)
6.2.2 Global Sertraline Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Sertraline Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Sertraline Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Sertraline Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Sertraline Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Sertraline Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Sertraline Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Sertraline Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Sertraline Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Sertraline Revenue by Region
7.1 Global Sertraline Revenue by Region
7.1.1 Global Sertraline Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Sertraline Revenue by Region (2020-2025)
7.1.3 Global Sertraline Revenue by Region (2026-2031)
7.1.4 Global Sertraline Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Sertraline Revenue (2020-2031)
7.2.2 North America Sertraline Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Sertraline Revenue (2020-2031)
7.3.2 Europe Sertraline Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Sertraline Revenue (2020-2031)
7.4.2 Asia-Pacific Sertraline Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Sertraline Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Sertraline Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Teva
8.1.1 Teva Comapny Information
8.1.2 Teva Business Overview
8.1.3 Teva Sertraline Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Teva Sertraline Product Portfolio
8.1.5 Teva Recent Developments
8.2 Sun Pharmaceutical
8.2.1 Sun Pharmaceutical Comapny Information
8.2.2 Sun Pharmaceutical Business Overview
8.2.3 Sun Pharmaceutical Sertraline Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Sun Pharmaceutical Sertraline Product Portfolio
8.2.5 Sun Pharmaceutical Recent Developments
8.3 Mylan
8.3.1 Mylan Comapny Information
8.3.2 Mylan Business Overview
8.3.3 Mylan Sertraline Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Mylan Sertraline Product Portfolio
8.3.5 Mylan Recent Developments
8.4 Pfizer
8.4.1 Pfizer Comapny Information
8.4.2 Pfizer Business Overview
8.4.3 Pfizer Sertraline Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Pfizer Sertraline Product Portfolio
8.4.5 Pfizer Recent Developments
8.5 Torrent Pharmaceuticals
8.5.1 Torrent Pharmaceuticals Comapny Information
8.5.2 Torrent Pharmaceuticals Business Overview
8.5.3 Torrent Pharmaceuticals Sertraline Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Torrent Pharmaceuticals Sertraline Product Portfolio
8.5.5 Torrent Pharmaceuticals Recent Developments
8.6 Oxford Pharma
8.6.1 Oxford Pharma Comapny Information
8.6.2 Oxford Pharma Business Overview
8.6.3 Oxford Pharma Sertraline Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Oxford Pharma Sertraline Product Portfolio
8.6.5 Oxford Pharma Recent Developments
8.7 Neurocon Inc
8.7.1 Neurocon Inc Comapny Information
8.7.2 Neurocon Inc Business Overview
8.7.3 Neurocon Inc Sertraline Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Neurocon Inc Sertraline Product Portfolio
8.7.5 Neurocon Inc Recent Developments
8.8 Lupin Pharmaceuticals
8.8.1 Lupin Pharmaceuticals Comapny Information
8.8.2 Lupin Pharmaceuticals Business Overview
8.8.3 Lupin Pharmaceuticals Sertraline Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Lupin Pharmaceuticals Sertraline Product Portfolio
8.8.5 Lupin Pharmaceuticals Recent Developments
8.9 Lifecare Neuro
8.9.1 Lifecare Neuro Comapny Information
8.9.2 Lifecare Neuro Business Overview
8.9.3 Lifecare Neuro Sertraline Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Lifecare Neuro Sertraline Product Portfolio
8.9.5 Lifecare Neuro Recent Developments
8.10 Healing Pharma India Pvt Ltd
8.10.1 Healing Pharma India Pvt Ltd Comapny Information
8.10.2 Healing Pharma India Pvt Ltd Business Overview
8.10.3 Healing Pharma India Pvt Ltd Sertraline Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Healing Pharma India Pvt Ltd Sertraline Product Portfolio
8.10.5 Healing Pharma India Pvt Ltd Recent Developments
8.11 Camber Pharmaceuticals
8.11.1 Camber Pharmaceuticals Comapny Information
8.11.2 Camber Pharmaceuticals Business Overview
8.11.3 Camber Pharmaceuticals Sertraline Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 Camber Pharmaceuticals Sertraline Product Portfolio
8.11.5 Camber Pharmaceuticals Recent Developments
8.12 Aurobindo Pharma
8.12.1 Aurobindo Pharma Comapny Information
8.12.2 Aurobindo Pharma Business Overview
8.12.3 Aurobindo Pharma Sertraline Sales, Price, Revenue and Gross Margin (2020-2025)
8.12.4 Aurobindo Pharma Sertraline Product Portfolio
8.12.5 Aurobindo Pharma Recent Developments
8.13 APOTEX
8.13.1 APOTEX Comapny Information
8.13.2 APOTEX Business Overview
8.13.3 APOTEX Sertraline Sales, Price, Revenue and Gross Margin (2020-2025)
8.13.4 APOTEX Sertraline Product Portfolio
8.13.5 APOTEX Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Sertraline Value Chain Analysis
9.1.1 Sertraline Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Sertraline Production Mode & Process
9.2 Sertraline Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Sertraline Distributors
9.2.3 Sertraline Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.